How does the TOBAS SRS registry change your approach to small AVMs in deep eloquent areas with prior rupture?

I emphasize that SRS is a reasonable attempt to reduce risk with about a 50–65% chance of cure at three years and a roughly 1 in 6 chance of a serious complication, including a 1 in 20 risk of another hemorrhage during follow‑up, and a 5-10% risk of brain injury from radiation-induced changes

Micros...